PharmiWeb.com - Global Pharma News & Resources
14-Feb-2023

LAMEA Biopsy Devices Market Report 2022: Featuring Medtronic, Hologic, Fujifilm, B.Braun Melsungen & More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "LAMEA Biopsy Devices Market Size, Share & Industry Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others, By End User, By Country and Growth Forecast, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.


The Latin America, Middle East and Africa Biopsy Devices Market should witness market growth of 12.7% CAGR during the forecast period (2022-2028).

Biopsies can be executed in the erect or decubitus location with these add-on structures. Thus, patients who surpass the weight limit of the table for the prone biopsy device are appropriate applicants for tomosynthesis-guided biopsies.

Also, patients with comorbidities (like respiratory issues, arthritic conditions, prior surgery, or limited mobility) that can stop them from lying on the radiosurgery table vulnerable for a long time are appropriate applicants for these biopsies.

Locating is much easier with the erect device as there is no disturbance from the biopsy table. In addition, posterior lesions are much easier biopsied as the erect perspective allows better entrance to the posterior tissues.

Compared to other Middle East countries, Egypt has a large healthcare sector. As the government of Egypt is intensely interested in growing the healthcare sector, Egypt bids a lot of prospects in developing medical services. In the past year, Egypt has raised public investment by 205%, allowing for the bolstering of the healthcare system during the pandemic.

The Brazil market dominated the LAMEA Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $53.1 million by 2028. The Argentina market is experiencing a CAGR of 13.3% during (2022-2028). Additionally, The UAE market would display a CAGR of 12.4% during (2022-2028).

Scope of the Study

By Product

  • Needle-based Biopsy Guns
    • Vacuum-assisted Biopsy (VAB) Devices
    • Fine Needle Aspiration Biopsy (FNAB) Devices
    • Core Needle Biopsy (CNB) Devices
  • Biopsy Guidance Systems
    • Manual
    • Robotic
  • Biopsy Needles
    • Disposable
    • Reusable
  • Biopsy Forceps
  • Others

By End-user

  • Hospitals
  • Diagnostic & Imaging Center
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Hologic, Inc.
  • Fujifilm Holdings Corporation
  • B.Braun Melsungen AG
  • Danaher Corporation
  • ConMed Corporation
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Argon Medical Devices, Inc.
  • Cook Medical, Inc.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. LAMEA Biopsy Devices Market by Product

Chapter 4. LAMEA Biopsy Devices Market by End User

Chapter 5. LAMEA Biopsy Devices Market by Country

Chapter 6. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/y45twg-biopsy?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 14-Feb-2023